Four of five top-ranked health plans operate in Mass., NCQA says
The National Committee on Quality Assurance has released a new ranking of nearly 500 private health insurance plans.
The National Committee on Quality Assurance (NCQA) has released a new evaluation of more than 500 private health plans, ranking 474 of them based on clinical performance, member satisfaction, and NCQA accreditation.
Eligibility for the rankings depended on each health plan’s public release of performance information and the submission of enough data for statistically valid analysis, according to NCQA. The top 10 health plans:
1. Harvard Pilgrim Health Care - HMO/POS (Massachusetts, Maine)
2. Tufts Associated Health Maintenance Organization - HMO/POS (Massachusetts)
3. Capital Health Plan - HMO (Florida)
4. Tufts Benefit Administrators - PPO (Massachusetts, Rhode Island)
5. Harvard Pilgrim Health Care - PPO (Massachusetts)
6. Kaiser Foundation Health Plan of Colorado - HMO (Colorado)
7. Harvard Pilgrim Health Care of New England - HMO/POS (New Hampshire)
8. Kaiser Foundation Health Plan of Northern California - HMO (California)
9. Group Health Cooperative of South Central Wisconsin - HMO (Wisconsin)
10. Kaiser Foundation Health Plan of Southern California - HMO (California)
Click here to see a full, detailed list of NCQA’s new rankings.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
